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Identification and characterization
of a human mitochondrial NAD kinase
Kazuto Ohashi1, Shigeyuki Kawai1 & Kousaku Murata1
NAD kinase is the sole NADPþ biosynthetic enzyme. Despite the great significance of
NADPþ , to date no mitochondrial NAD kinase has been identified in human, and the source
of human mitochondrial NADPþ remains elusive. Here we present evidence demonstrating
that a human protein of unknown function, C5orf33, is a human mitochondrial NAD kinase;
this protein likely represents the missing source of human mitochondrial NADPþ.
The C5orf33 protein exhibits NAD kinase activity, utilizing ATP or inorganic polyphosphate,
and is localized in the mitochondria of human HEK293A cells. C5orf33 mRNA is more
abundant than human cytosolic NAD kinase mRNA in almost all tissues examined.
We further show by database searches that some animals and protists carry C5orf33
homologues as their sole NADPþ biosynthetic enzyme, whereas plants and fungi possess
no C5orf33 homologue. These observations provide insights into eukaryotic NADPþ
biosynthesis, which has pivotal roles in cells and organelles.
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N
ADþ , NADPþ and their reduced forms (NADH and
NADPH) function as cofactor involved in oxidative–
reductive reactions1,2. NADþ and NADH mainly
function in catabolic reactions, whereas NADPþ and NADPH
are involved in anabolic reactions and defence against oxidative
stress3. NADþ and NADPþ are also known to function as
substrates in several reactions1,2,4–7. NAD kinase (NADK; EC
2.7.1.23) is the sole NADPþ -biosynthetic enzyme known to
catalyse phosphorylation of NADþ to yield NADPþ , using
ATP or inorganic polyphosphate (poly(P)) as the phosphoryl
donor1, and has a vital role in the cell. Poly(P) is a linear polymer
of orthophosphate residues linked by energy-rich phosphoan-
hydride bonds; it has been found in bacteria, fungi and tissues of
higher plants and animals, including humans8,9. Some bacterial
and archaeal NADKs utilize both poly(P) and ATP as a
phosphoryl donor, although all characterized eukaryotic
NADKs use ATP, not poly(P)10. Moreover, some bacterial and
eukaryotic NADKs also catalyse the phosphorylation of NADH
by utilizing ATP to yield NADPH (NADH kinase (NADHK; EC
2.7.1.86) reaction)10. NADKs that have higher NADHK activity
than NADK activity have also been identified, and in some cases
classified as NADHK. So far, only mitochondrial Pos5 of the yeast
Saccharomyces cerevisiae and peroxisomal NADK3 of the plant
Arabidopsis thaliana have been experimentally defined as
NADHK3,11–13.
In the case of yeast, in addition to the gene (POS5) encoding
mitochondrial Pos5, S. cerevisiae has other two NADK genes
(UTR1 and YEF1) encoding cytosolic Utr1 and Yef1 (refs 3,14,15).
The NADK triple mutant (utr1 yef1 pos5) is lethal11,16,17,
emphasizing the significance of intracellular NADP(H)
biosynthesis. The phenotypes of the POS5 mutant (pos5), which
are probably caused by decreased mitochondrial NADPH,
indicate that Pos5 is responsible for mitochondrial NADP(H)
synthesis and again emphasizes the importance of mitochondrial
NADP(H)3,11,12,17. Moreover, in addition to the gene (NADK3)
encoding peroxisomal NADK3, NADK1 and NADK2 have been
identified as NADK genes in A. thaliana13,18. The products of
these genes, NADK1 and NADK2, are localized in the cytosol and
chloroplast, respectively19. In pea leaf, NADPþ enters the plant
mitochondria20; thus, the NADPþ transporter, which is localized
in the inner membrane of mitochondria, is responsible for the
supply of plant mitochondrial NADPþ . In phylogenetic tree
analysis, the plant NADK3 homologues, including A. thaliana
NADK3, are distinguishable from NADK homologues, including
Pos5 and Utr1 (ref. 21). However, the structural features of
NADK3 homologues have not been reported.
In contrast to yeasts and plants, only a single gene encoding
NADK has been found in the human genome; the product of this
gene, human NADK, is localized to the cytosol22,23. No
mitochondrial NADK has been found in human. Pollak et al.23
stated that given the vital role of at least two NADK isoforms in
yeast, one would certainly expect more than one mammalian
NADK isoform; furthermore, any additional NADK isoforms in
mammals should have primary structures substantially
different from virtually all previously identified enzymes, at
least according to the currently available information1. An influx
of NADþ through human and mammal mitochondrial
membrane has been reported24,25, but the source of human
mitochondrial NADPþ has remained elusive despite its great
significance.
In this study, we identified C5orf33, a human protein of
unknown function, as an NADK3 homologue, based on
homology search using the primary structure of NADK3 of
A. thaliana as a query. The C5orf33 protein is a novel human
mitochondrial NADK that is responsible for the missing source of
mitochondrial NADPþ in human cells.
Results
C5orf33 is a candidate human mitochondrial NADK. A.
thaliana NADK3 homologues are distinguishable from NADK
homologues on the phylogenetic tree21, although there has been
no report of the features of the primary structure of NADK3. To
obtain more information, we performed a BLASTP26 search using
the primary structure of NADK3 as a query against all organisms
in KEGG (Kyoto Encyclopedia of Genes and Genomes website,
http://www.genome.jp/kegg/); 1,127 proteins were detected as
NADK3 homologues (E-values, e-179 to 9.9) with E-values less
than 10. Human C5orf33 protein was unexpectedly detected as
the 134th homologue (E-value, 9e-06), whereas human NADK
was detected as the 833rd homologue (E-value, 0.25). When
BLASTP search was conducted using the primary structure of
human NADK as a query, human C5orf33 protein was not
included in the detected human NADK homologues (total 1,854
proteins; E-values ranging from 0.0 to 6.1) as reported
previously1, although the C5orf33 protein contains an NADK
motif (Pfam, PF01513 (ref. 27)) (Fig. 1a). NADK3 was detected as
the 1,817th homologue (E-value, 0.49) among human NADK
homologues.
BLASTP analysis showed that the primary structure of human
C5orf33 protein (442 amino-acid residues) is 25% identical (37%
similar) to that of NADK3 (317 residues). Moreover, using
Mitoprot, we identified a mitochondrial-targeting sequence in the
N-terminus of the primary structure of the C5orf33 protein28
(Fig. 1a). These features of the primary structure suggested that













































Figure 1 | Structure of C5orf33 protein. (a) Primary structures of the
C5orf33 protein and its truncations. Predicted mitochondrial-targeting
sequence and NADK motif are in black and grey, respectively. The
amino-acid residue numbers are indicated on the structures. Asterisk
in parentheses (*) indicates the start codon found in pMK3270 and
pMK3243, but not in the sequence of C5orf33 variant 1. (b) mRNA
structures of C5orf33 transcript variants 1 and 2. Grey arrows indicate open
reading frames encoding the indicated proteins. The nucleotide (nt) base
and amino-acid (aa) residue numbers are shown. The nucleotide sequences
indicated by double-headed arrows are identical between variants 1 and 2.
The putative start codon (ATG) is denoted by an asterisk (a,b).
The nucleotide sequence of C5orf33 variant 2 (62CTTGCATTGAAAGGC
TCTAGTTAC85) corresponds to the N-terminal region of the D100C5orf33
protein (101LALKGSSY108) (a,b).
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In vivo assay of NADK activity using S. cerevisiae. Two
complementary DNAs corresponding to mRNAs from the
human C5orf33 gene, transcript variant 1 (accession no.
NM_001085411.1) and transcript variant 2 (accession no.
NM_153013.3), are deposited in the NCBI database. Transcript
variant 1 encodes full-length C5orf33 protein (442 residues)
(Fig. 1a,b; Supplementary Fig. S1). Transcript variant 2 encodes
the C5orf33 protein lacking N-terminal 163 amino acids
(D163C5orf33 protein, 279 residues) (Fig. 1a,b). Note that variant
2 also is encompassed by D100C5orf33 protein (342 residues;
Fig. 1a,b). The NADK activity of C5orf33, D62C5orf33,
D100C5orf33 and D163C5orf33 proteins (Fig. 1a) were examined
using the S. cerevisiae NADK triple mutant utr1 yef1 pos5.
D62C5orf33 protein lacks the 62-residue predicted mitochon-
drial-targeting sequence. As shown in Fig. 2a, MK1598 cells
(an NADK triple mutant having YCplac33-UTR1) carrying
pRS415 alone were inviable on synthetic complete (SC)þ
5-fluoroorotic acid (FOA) due to the loss of YCplac33-UTR1 and
the lethality of the resultant utr1 yef1 pos5 cell11. However,
MK1598 cells carrying an additional S. cerevisiae mitochondrial
NADHK gene (POS5) on pRS415 (pMK2127) were viable on
SCþ FOA, although YCplac33-UTR1 was dropped (Fig. 2a),
indicating that the NADHK activity of Pos5 rescued the lethality
of the utr1 yef1 pos5 cells. MK1598 cells carrying the gene
encoding either the full-length C5orf33 protein (pMK3269) or the
D62C5orf33 protein (pMK3270) were viable on SCþ FOA
medium, but those carrying the D100C5orf33 gene (pMK3243)
or the D163C5orf33 gene (pMK3244) were not, indicating that
the C5orf33 and D62C5orf33 proteins exhibit NADK or NADHK
activity.
In vitro NAD(H)K activities of purified C5orf33. To confirm
the NADK or NADHK activity of C5orf33 protein in vitro, we
expressed recombinant C5orf33 and D62C5orf33 proteins
in Escherichia coli Rosetta-gami(DE3)pLysS as described in
Methods, Supplementary Methods and Supplementary Table S1.
C5orf33 was expressed as an insoluble protein, whereas
D62C5orf33 protein was partially soluble: B28% of D62C5orf33
protein was soluble and 72% was insoluble (Supplementary
Methods). We purified the soluble D62C5orf33 protein using
TALON column chromatography; the resulting product is
referred to hereafter as ‘purified C5orf33 protein’ (Fig. 2b).
SDS–PAGE analysis showed that the molecular mass of the
purified C5orf33 protein was 43 kDa, in agreement with the
predicted mass (45 kDa; His-tag (1.4 kDa) plus D62C5orf33
protein (43.3 kDa)). We assayed the NADK activity of C5orf33
protein using ATP and poly(P) (metaphosphate) as a phosphoryl
donor; by thin layer chromatography (TLC) analysis, we detected
the formation of NADPþ from NADþ and of ADP from
ATP (Fig. 2c), showing that C5orf33 protein has NADK activity
using ATP and poly(P) as phosphoryl donors.
The kinetic properties of C5orf33 protein were determined by
assay of NADK activity using the continuous method (see
Methods), and compared with those of human NADK29
(Table 1). Both Km (for NADþ ) and Vmax of C5orf33 protein
(0.022±0.001mM and 0.091±0.001Umg 1) were significantly
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Figure 2 | NADK activity of C5orf33 protein. (a) In vivo assay of NADK
activity of C5orf33 protein. S. cerevisiae MK1598 cells (an NADK triple
mutant having YCplac33-UTR1) carrying the indicated plasmids were
spotted onto the solid media and were incubated at 30 1C for 4 days.
C5orf33 protein was less effective than D62C5orf33 protein in reverting the
lethality. We speculate that this is because in the yeast, human C5orf33 is
less able to supply cytosolic NADPþ than the yeast mitochondrial Pos5
itself. (b) SDS–PAGE of purified C5orf33 protein (arrowhead; 43 kDa).
(c) NADK activity of purified C5orf33 protein analysed by TLC in the
presence (þ ) or absence ( ) of indicated compounds as described in
the Methods. (d) Saturation curves for NADþ of purified human NADK
(dashed line)29 and C5orf33 protein (line) determined under 8 and
2mM ATP, respectively. The specific activity (U mmol 1; 1mmol NADPþ
produced per 1min and 1mmol subunit of the enzyme) was calculated
using the subunit molecular mass of C5orf33 protein (45 kDa) or human
NADK (43 kDa) (Table 1). Each point represents the average of three
determinations; error bars represent s.d.
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(Table 1). However, at the physiological concentrations of NADþ
found in human mitochondria and cytosol, the NADK activity of
C5orf33 protein would be comparable to that of human NADK,
as described in the Discussion (Fig. 2d). With regard to the
substrate specificity of C5orf33 protein, the NADHK activity of
C5orf33 protein was only 10% of its NADK activity (Table 1),
although the primary structure of C5orf33 protein is similar to
that of NADHK (NADK3 (ref. 13)). ATP-dependent nicotinic
acid adenine dinucleotide (NAAD) kinase activity of C5orf33
protein was not detected by TLC. NAAD phosphate (NAADP),
the phosphorylated NAAD, is a calcium-mobilizing second
messenger in human6,7. Although NADKs (Utr1 and Yef1) of
S. cerevisiae catalyse NAADP synthesis by phosphorylation
of NAAD16, human NADK has no NAAD phosphorylation
activity22. Furthermore, TLC analysis detected no phosphory-
lation of either ADP-ribose, adenosine or 50-AMP by C5orf33
protein. Sphingosine kinase, diacylglycerol kinase and
6-phosphofructokinase activities of purified C5orf33 protein
were assayed by monitoring formation of ADP, as described in
Supplementary Methods. Although formation of ADP was
observed in the presence of NADþ even in the presence
of vehicle alone (16% (v/v) dimethylformamide or 10% (v/v)
ethanol), formation of ADP in the presence of sphingosine,
diacylglycerol (1,2-dioleoyl-sn-glycerol) and fructose 6-phosphate
was not, indicating that purified C5orf33 protein exhibits no
sphingosine kinase, diacylglycerol kinase or 6-phosphofructo-
kinase activity, although these kinases have been suggested to be
weakly related to NADK with respect to structure and function30.
On the other hand, as phosphoryl donors, C5orf33 protein
could use ATP, other nucleotide triphosphates and poly(P)
(metaphosphate, hexametaphosphate and tetrapolyphosphate),
but neither ADP, trimetaphosphate, phosphoenolpyruvate nor
phosphocreatine (Table 1). It should be noted that C5orf33
protein exhibits a poly(P)-dependent NADK activity comparable
to that of its ATP-dependent activity, as it has been postulated
that only a subset of bacterial or archaeal NADKs exhibit high
poly(P)-dependent NADK activity, whereas eukaryotic NADKs
do not10. Moreover, C5orf33 protein exhibited a saturation curve
with ATP (Supplementary Fig. S2), whereas human NADK
exhibited sigmoidal kinetics with ATP29.
Although human NADK is inhibited by NADH and NADPH,
but not NADPþ (ref. 29), the NADK activity of C5orf33 protein
was inhibited by NADH, NADPH and in particular NADPþ
(Table 1).
Mitochondrial localization of C5orf33 protein. C5orf33 protein
was predicted to be localized in mitochondria because of the
presence of a mitochondrial-targeting sequence (Fig. 1a). An
in vivo assay of C5orf33 protein localization in S. cerevisiae
indicated that the C5orf33 protein is localized in mitochondria of
S. cerevisiae, whereas D62C5orf33 protein that lacks the mito-
chondrial-targeting sequence is not (Supplementary Fig. S3). To
confirm the localization of C5orf33 protein in mitochondria of
human cells, HEK293A cells were transiently transfected with a
plasmid expressing C terminally FLAG-fused C5orf33 protein or
D62C5orf33 protein, and observed by fluorescence microscopy
after immunostaining (Fig. 3). This observation demonstrated
that the C5orf33 protein is localized in mitochondria, whereas
D62C5orf33 protein is not, confirming that C5orf33 protein is a
mitochondrial NADK, and that its N-terminal 62 residues con-
tain a functional mitochondrial-targeting sequence. Moreover, we
separated the mitochondrial and cytosolic fractions of siRNA-
transfected HEK293A cells and confirmed using anti-C5orf33
antibody that C5orf33 protein was localized in the mitochondrial
fraction but not in the cytosolic fraction as below (Fig. 5e).
Widespread expression of C5orf33 mRNA. To determine
whether C5orf33 gene is transcribed in human tissue under
physiological conditions, tissue-specific transcription of mRNAs
Table 1 | Properties of C5orf33 protein and human NADK.
C5orf33 protein Human NADK*
Molecular mass (subunit) 75 kDa (45 kDa) 170 kDa (43 kDa)
Subunit composition Homodimerw Homotetramer
Km (ATP) 1.7±0.3mM 3.6mMz




 1 || 18.5Umg 1
Localization Mitochondria Cytosolz
Phosphoryl acceptor# NADþ (100), NADH (10), NAAD (n.d.**), ADP-ribose
(n.d.), Adenosine (n.d.), 50-AMP (n.d.), Sphingosine (n.d.),
Diacylglycerol (n.d.), Fructose 6-phosphate (n.d.)
NADþ (100), NADH (5.0), NAAD (n.d.)ww
Phosphoryl donorzz ATP (100), dATP (99), ADP (n.d.), GTP (162), CTP (56),
TTP (87), UTP (41), ITP (104), dITP (141), Metaphosphate
(280), Hexametaphosphate (194), Tetrapolyphosphate
(84)yy, Trimetaphosphate (n.d.), Tripolyphosphate (n.d.),
Phosphoenolpyruvate (n.d.), Phosphocreatine (n.d.)
ATP (100), Metaphosphate (2.3), Hexametaphosphate
(1.9), Tetrapolyphosphate (0.5)
Inhibition|||| None (100), NADH (34), NADPþ (58), NADPH (17) None (100), NADH (40), NADPþ (102), NADPH (81)
*Almost all of these data were determined previously29.
wSubunit composition was regarded as homodimeric, as the molecular mass of purified C5orf33 was estimated to be B75 kDa.
zS0.5 is shown, as human NADK exhibits sigmoidal kinetics towards ATP29.
yNot determined because the tetrapolyphosphate-dependent NADK activity (0.5%) of human NADK is much lower than the ATP-dependent activity.
||Vmax for NAD
þ . Vmax for ATP and tetrapolyphosphate were 0.088±0.005 and 0.095±0.004Umg 1, respectively.
zDemonstrated previously23.
#The relative NADK activities determined in the presence of 2mM phosphoryl acceptors are shown, taking the activity in 2mM NADþ as 100%.
**Not detected.
wwDemonstrated previously22.
zzThe relative NADK activities determined in the presence of 5mM phosphoryl donors, 2.4mgml 1 metaphosphate, or 2.4mgml 1 hexametaphosphate are shown, taking the activity in 5mM ATP as
100%.
yyNADK activity yielded a saturation curve up to 4mM tetrapolyphosphate; the activity was slightly inhibited in this assay condition (that is, at 5mM tetrapolyphosphate).
||||The NADK activities of C5orf33 protein and human NADKwere assayed in the presence of 1mM NADþ with or without 0.5mM NADPþ , NADH or NADPH. For each protein, activity in the absence of
inhibitor was taken as 100%. The inhibitory effect of NADH could not be attributed to the NADHK activity of C5orf33 protein alone, as the NADHK activity assayed in the presence of 0.5mM NADH was
only 13% of the NADK activity assayed in the presence of 1mM NADþ .
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2262
4 NATURE COMMUNICATIONS | 3:1248 | DOI: 10.1038/ncomms2262 | www.nature.com/naturecommunications
& 2012 Macmillan Publishers Limited. All rights reserved.
encoding C5orf33 protein, human NADK and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) were examined by abso-
lute qPCR. The gene encoding GAPDH was selected as a
housekeeping gene31,32. For absolute qPCR, standard curves were
created using synthesized mRNAs of the genes encoding C5orf33
proteins, human NADK and GAPDH. As shown in Fig. 4, the
presence of mRNAs encoding C5orf33 protein, human NADK
and GAPDH were confirmed in all examined tissues. The relative
levels of transcripts of the GAPDH gene in testes, small intestine,
colon, stomach and placenta were in agreement with those
reported32, guaranteeing the quality of the RNAs at least in these
tissues. The mRNA levels of C5orf33 protein and human NADK
were only a few per cent of the levels of GAPDH (for example,
only 2.1% (human NADK gene) and 7.8% (C5orf33 gene) in
brain) (Fig. 4a). However, levels of C5orf33 mRNA were higher
than those of the human NADK gene in all tissues examined
except for colon, spleen and skeletal muscle (Fig. 4b). In
particular, C5orf33 mRNA levels were significantly higher than
human NADK mRNA levels in heart, liver, testes and small
intestine. The mRNA levels of both genes were low in skeletal
muscle, possibly reflecting the virtual absence of both the pentose
phosphate and the fatty acid synthetic pathways in this tissue22.
C5orf33 affects mitochondrial reactive oxygen species (ROS)
generation. To obtain information regarding the physiological
role of C5orf33 protein, we knocked down the human C5orf33
gene by siRNA transfection of HEK293A cells. Of the six siRNA
duplexes we tested (Supplementary Table S2), transfection with
siRNA#2 resulted in maximum C5orf33 knockdown (B70%
reduction) and siRNA#2 was selected for subsequent knockdown
experiments (Supplementary Methods and Fig. 5a).
At 2 or 3 days after transfection with siRNA#2, we observed
substantial knockdown at the mRNA level (Fig. 5a). At 3 days
after transfection with either siRNA#2 or MISSION siRNA
Universal Negative Control #1 (control siRNA), C5orf33 mRNA
levels were higher than those in the corresponding samples that
had been incubated for 1 or 2 days after transfection. We also
made observations at the protein level, using anti-C5orf33 anti-
body. We detected obvious knockdown of C5orf33 protein levels
at 2 days and especially 3 days after transfection, but not after a 1-
day incubation (Fig. 5b). In accordance with the relative increase
in C5orf33 transcript level 3 days after transfection, the absolute
level of C5orf33 protein was highest at this time point. The anti-
C5orf33 antibody was specific for purified C5orf33 protein,
and did not detect purified human NADK, guaranteeing
that the signal we detected accurately represented C5orf33 pro-
tein rather than a cross-reaction with NADK (Supplementary
Fig. S4). By contrast, the anti-human NADK antibody was non-
specific, detecting both C5orf33 protein and human NADK
(Supplementary Fig. S4).
Next, we evaluated the effect of the C5orf33 knockdown.
Mitochondrial morphology was not affected by knockdown of






Figure 3 | Localization of C5orf33 protein in mitochondria of human cells.
HEK293A cells were transiently transfected with plasmid expressing C
terminally FLAG-tagged C5orf33 or D62C5orf33 protein. The cells were
fixed and immunostained with a rabbit anti-FLAG primary antibody and
AlexaFluor 488-conjugated anti-rabbit secondary antibody. Mitochondria






















































































































Figure 4 | Tissue-specific mRNA levels determined by absolute qPCR.
mRNAs of C5orf33 protein (dark grey), human NADK (light grey) and
GAPDH (white bars) (a); only those of the C5orf33 protein and human
NADK are shown in panel b. Means and s.d. of three determinations are
shown.
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During this period, cell viability was also unaffected by knock-
down, even in the presence of menadione (Supplementary Fig. S5,
Fig. 5c). However, intracellular ROS levels were obviously
increased 3 days after knockdown of C5orf33, but not 1 and 2
days, either in the absence or presence of menadione, although
ROS levels were higher following menadione treatment
(Supplementary Fig. S5, Fig. 5d). Menadione is cytotoxic to var-
ious cell lines, including HEK293 (refs 33,34), and induces
apoptosis of cultured cells via elevation of peroxide and super-
oxide radical levels35. Moreover, we separated the mitochondrial
and cytosolic fractions of HEK293A cells that had been incubated
for 3 days after transfections with siRNA#2 and control siRNA,
and again confirmed the mitochondrial localization of C5orf33
protein as well as the knockdown of C5orf33 protein level in
mitochondrial fraction of siRNA#2-transfected cells, using anti-
C5orf33 antibody (Fig. 5e). NADK activity of the mitochondrial
fraction was decreased to 47% upon knockdown of C5orf33
(Fig. 5f). These observations indicate that C5orf33 protein, that is,
human mitochondrial NADK is involved in the regulation of the
generation of mitochondrial ROS.
Discussion
Only a single gene encoding NADK has been previously reported
to exist in the human genome; the product of this gene, human
NADK, is localized in cytosol22,23. Until now, no mitochondrial
NADK had been identified in human. Thus, the source of human
mitochondrial NADP(H) has been elusive despite its great
significance. In this study, it was revealed that the C5orf33
protein is a novel human mitochondrial NADK that is
responsible for the missing source of mitochondrial NADPþ in
human cells. In HEK293 human cells, the concentration of
NADþ in whole cells and mitochondria are 0.37 and 0.25mM,
respectively36. Given that mitochondria occupy 15% of the
volume of a neuron37, we estimated the cytosolic concentration of
NADþ to be 0.39mM. On the other hand, the concentration of
ATP, which complexed with magnesium, is estimated to be 2 and
8mM in mitochondria and cytosol of HeLa cell, respectively38.
From a saturation curve determined in the presence of 2mM
ATP (the physiological concentration within mitochondria)38, we
estimated the NADK activity of C5orf33 protein at 0.25mM
NADþ to be 3.5U per 1 mmol of C5orf33 protein (Fig. 2d). In the
same manner, the activity of human NADK at 0.39mM NADþ
was estimated to be 12U per 1 mmol of human NADK subunit in
the presence of 8mM ATP (cytosolic concentration of ATP)38
(Fig. 2d). Moreover, C5orf33 mRNA levels were higher than those
of human NADK in almost all tissues (Fig. 4). Collectively,
although the Vmax of C5orf33 protein is significantly lower than
that of human NADK (Table 1), under physiological conditions
the NADK activity of the C5orf33 protein would be comparable
to that of human NADK.
BLASTP analyses using each of the primary structures of
human C5orf33 protein and human NADK as a query in





































































































Figure 5 | siRNA transfection. HEK293A cells were transfected with
siRNA#2 against C5orf33 protein (C5orf33 siRNA) or control siRNA,
and incubated for 1, 2 and 3 days. (a) Levels of C5orf33 mRNA in the
transfected cells are shown as relative values normalized against the level
in control siRNA-transfected cells incubated for 1 day after transfection.
Knockdowns of 69, 63 and 79% relative to the control, as indicated,
were obtained. (b) Expression of C5orf33 protein in the transfected cells.
Proteins were analysed by western blotting using anti-C5orf33 and
anti-GAPDH antibodies. (c) Viability. Transfected cells incubated for 3 days
were treated with 12.5 mM menadione (black bar) or vehicle (0.62% (v/v)
dimethyl sulfoxide (DMSO), grey bar) for 20 h, and viability was measured
using calcein AM as in Supplementary Methods. Viability was also
measured using MTT as in Supplementary Fig. S5. (d) Intracellular ROS
levels. Transfected cells incubated for 3 days were incubated with 10mM
5-(and-6)-chloromethyl-20,70-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA) for 30min, and then treated without (grey bar)
or with (black bar) 100 mM menadione for 30min; intracellular ROS was
measured as described in Supplementary Methods. t-test; *P¼0.0085,
**P¼0.0026, ***P¼0.0022, ****P¼0.0044 104. Viability and
intracellular ROS levels are presented as relative values normalized against
their respective levels in control siRNA-transfected cells not treated with
menadione; each independent experiment was conducted in duplicate (c,d).
(e) Mitochondrial and cytosolic fractions of HEK293A cells that had been
incubated for 3 days after transfections. Mitochondrial (M; 1.9mg) and
cytosolic (C; 1.9 mg) fractions and whole cells (W; from 3.3 104
transfected HEK293A cells) were analysed by western blotting using anti-
CoxII, anti-GAPDH and anti-C5orf33 antibodies. CoxII and GAPDH are
mitochondrial and cytosolic markers, respectively49. (f) NADK activity of
mitochondrial fraction obtained in panel e. Mitochondrial NADK activity is
expressed as pmol of NADPþ formed in 1 h. NADK activity was decreased
to 47% upon knockdown of C5orf33. t-test; *P¼0.024. Means and s.d. of
three independent determinations are shown (a,c,d,f).
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and 316 human NADK homologues, all of which contain the
NADK motif. Phylogenetic trees constructed based on the
structures of the 107 proteins as described in Supplementary
Methods gave three clades: (i) animal and protist proteins
including the human C5orf33 protein (total 65 proteins; E-values
from 0.0 to 0.074); (ii) plant proteins including NADK3 (18
proteins; E-values from 8e 11 to 0.049); and (iii) other proteins
from several eukaryotes (24 proteins; E-values from 0.017 to 5.4)
(Supplementary Fig. S6). These clades were, respectively,
designated as (i) C5orf33 homologues, (ii) plant NADK3
homologues and (iii) NADK homologues. The 24 other proteins
from several eukaryotes were found in 316 human NADK homo-
logues, gave much lower E-values ranging from 0.0 to 4e 51,
and hence were designated as NADK homologues. Predicted
mitochondrial-targeting sequences were detected in the primary
structures of 38 of 65 C5orf33 homologues, and 4 of 18 plant
NADK3 homologues, but not in 24 NADK homologues
(Supplementary Fig. S6). Given that eukaryotes consist of animals
(for example, vertebrates and insects), protists, plants and fungi,
we concluded that animals and protists, but not plants and fungi,
have C5orf33 homologues. C5orf33 homologues were found in
almost all animals and many protists; 48 of 52 animals and 13 of
29 protists. Although 42 of 52 animals and 5 of 29 protists possess
both C5orf33 and NADK homologues, some carry only either a
C5orf33 homologue or NADK homologue; one protist (Naegleria
gruberi) has none (Supplementary Table S3). It is noteworthy
that six animals (for example, pig and horse) and eight protists
(for example, those in genus Plasmodium) possess the C5orf33
homologue as sole NADPþ biosynthetic enzyme.
We performed multiple alignment of the primary structures
of human C5orf33 protein, plant NADK3 and nine NADKs
(Supplementary Fig. S7). The GGDG motif39, NE/D short
motif40, and the Asp, Thr and Tyr residues (corresponding
to Asp-189, Thr-200 and Tyr-202 of Ppnk (NADK of
Mycobacterium tuberculosis) and taking part in the creation of
NADþ -binding site) in the NADK-conserved region40,41 are
completely conserved in the primary structures of the nine
NADKs. In the structure of the C5orf33 protein, although the
GGDG motif and NE/D short motif were completely conserved,
the Asp, Thr and Tyr residues were not, corresponding instead to
Ser-306, Lys-317 and Trp-319. We also found an additional
region, termed the C5orf33 additional region, in the structure of
the C5orf33 protein. In the sequence of NADK3, the GGDG
motif and NE/D short motif are conserved; the Asp, Thr and Tyr
residues were Ser-209, Thr-220 and Ala-222; and the NADK3
additional region, which does not correspond to the C5orf33
additional region, is found.
In the aligned structures of 65 C5orf33 homologues, the GGDG
motif was conserved in 58 of 65 structures; the NE/D short motif
was completely conserved (that is, in 65 of 65 structures)
(Supplementary Fig. S7). With regard to the Ser-306, Lys-317 and
Trp-319 of the human C5orf33 protein, the Ser-306 was conserved
as Ser/Thr, the Trp-319 was completely as Trp, although the Lys-
317 was not conserved and corresponded to Lys/Ser/Thr/Arg. In
the aligned structures of C5orf33 homologues, we found two
conserved sequences, motif 1 and motif 2. Motif 1 is PX-GXN(T/
S)DP; motif 2 is S-G-X(C/M), where X and hyphen (-) mean
hydrophobic (Ile, Phe, Val, Leu and Met) and any amino-acid
residues, respectively. Of the aligned 65 sequences, 50 possessed
both motifs; of the remaining 15 sequences, 3 contained motif 1
alone, 8 contained motif 2 alone and 4 contained neither. The
sequences corresponding to the C5orf33 additional region were also
found in 62 of the 65 aligned sequences.
In the aligned structures of 18 plant NADK3 homologues, the
GGDG motif, the NE/D short motif and motif 1 were completely
conserved (in 18 of 18 sequences); motif 2 was almost completely
conserved (in 17 of 18 sequences). The Ser-209, Thr-220 and Ala-
222 residues of NADK3, corresponding to Asp-189, Thr-200 and
Tyr-202 of Ppnk, were conserved as Ser, Thr/Ser and Ala
residues. Sequences corresponding to the NADK3 additional
region were found in 17 of the 18 sequences (Supplementary
Fig. S7). Taken together, these structural features may contribute
to the unique properties of human C5orf33 protein, that is, high
capacity to utilize poly(P), as well as low Km and low Vmax, and
inhibition by NADPþ and of plant NADK3, that is, low Km and
high Vmax for NADH13, possibly by using a different set of active-
site side chains.
Methods
Plasmids. The plasmids and primers used in this study are listed in Supplementary
Tables S4 and S5. Briefly, pMK2127 is pRS415 carrying the POS5 promoter (Ppos5)
driving POS5 (ref. 11). Genes encoding C5orf33 (full-length) and its truncations
(Fig. 1a) were inserted into downstream Ppos5 by replacing POS5 of pMK2127 with
these genes. Genes encoding C5orf33 and its deleted proteins were also inserted
into BamHI/SmaI site of pQE-80L (Qiagen), yielding pMK3271, pMK3272 and
pMK3241, respectively. These proteins were expressed as His
(MRGSHHHHHHGS; 1.4 kDa)-tagged proteins to their N-termini. For expression
of C terminally FLAG-tagged human C5orf33 and D62C5orf33 proteins in
HEK293A cells, cDNAs of human C5orf33 and D62C5orf33 were inserted into
pFLAG-CMV-5a (Sigma), yielding pMK3602 and pMK3603, respectively.
For absolute qPCR, DNA sequences corresponding to cDNA of human GAPDH
(1,310 bp; 1,008 bp of GAPDH gene, 50-flanking 102 bp and 30-flanking 200 bp),
human NADK (3,032 bp; 1,341 bp of human NADK gene, 50- 42 bp, 30- 1,649 bp),
and C5orf33 variant 1 (3,852 bp; 1,324 bp of C5orf33 gene and 30- 2,528 bp) were
inserted into pBluescript II SK (þ ), yielding pMK3420, pMK3421 and pMK3422,
respectively. Accurate synthesis of all the constructed plasmids was confirmed
by DNA sequencing.
Yeast strains and cultivations. For the cultivation of yeast, standard yeast media
(yeast extract/peptone/dextrose, SC and synthetic dextrose media) were used42.
If required, amino acids were added to synthetic dextrose medium. Liquid medium
were solidified using 2% agar. Yeast cells were cultured aerobically at 30 1C. For
plasmid shuffling, solid SC medium containing 0.1% FOA (SCþ FOA medium)
was used. FOA is toxic for the cells containing URA3 (ref. 43).
S. cerevisiae strains in BY4742 background (MATa leu2D0 lys2D0 ura3D0
his3D1) were used. S. cerevisiae MK1598 cell is an NADK triple mutant carrying
YCplac33-UTR1 (BY4742 utr1D::kanMX4 yef1D::HIS3 pos5D::hphMX4 YCplac33-
UTR1) and is lethal on SCþ FOA medium11,16.
In vitro assays. NADK activity of purified C5orf33 protein was assayed at 37 1C
by the modified continuous method as described previously29. Briefly, NADPH
formation was continuously measured at A340 in a reaction mixture (1ml)
containing 5mM NADþ , 5mM ATP, 5mM glucose 6-phosphate, 0.5U glucose
6-phosphate dehydrogenase (Sigma, St Louis, MD), 5mMMgCl2 (40mMMgCl2 in
the case of the determination of Km and Vmax for ATP, 20mM MgCl2 in that of Km
and Vmax for NADþ ), 100mM Tris-HCl (pH 8.0) and appropriate concentration
of purified protein. NADK activity was also assayed by a stop method as described
previously29. When NADK activity was analysed by TLC, 5 ml of the reaction
mixture containing 5mM NADþ , 5mM MgCl2, 100mM Tris–HCl (pH 8.0),
4.8 mg of purified C5orf33 protein and 5mM ATP or 2.4mgml 1 metaphosphate
was incubated overnight at 37 1C. Metaphosphate was used at 2.4mgml 1, as
2.4mgml 1 sodium tetrapolyphosphate is 5mM. Authentic compounds and the
incubated reaction mixture were spotted onto a TLC glass plate silica gel 60F254
(Merck), dried, developed with a solvent system of isobutyrate—500mM NH4OH
(5:3 v/v)44 and detected by exposure to UV light at 254 nm. The inhibitory effects
of NADPþ , NADH and NADPH on NADK assay were investigated
by a stop method as described previously29. The NADHK activity was assayed as
described previously29 in a reaction mixture (1ml) containing 2mM NADH, 5mM
ATP, 5mM MgCl2, 100mM Tris–HCl (pH 8.0) and purified protein. NADK
activity of C5orf33 protein was determined by a stop method to compare it with
the NADHK activity of the enzyme. NADK activity of mitochondrial fraction was
also assayed by the stop method in the reaction mixture as above (40 ml; 5mM
NADþ , 5mM ATP, 5mM MgCl2, 100mM Tris–HCl (pH 8.0) and mitochondrial
preparations (1.4–35 mg protein)) followed by cycling assay of NADPþ as
described45. In each experiment, the assays were linear with respect to both
times (0, 1 and 2 h) and concentrations of mitochondrial preparations (at least
two points).
One unit of enzyme activity was defined as 1 mmol NADPþ or NADPH
produced in 1min at 37 1C; specific activity was expressed in Umg 1 protein,
unless otherwise stated. Kinetic values were calculated by fitting the data to the
appropriate Michaelis–Menten equations using KaleidaGraph software (Synergy
Software).
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Expression and purification of C5orf33 protein. To express C5orf33 and
D62C5orf33 proteins, MK3274 and MK3275 cells (E. coli Rosetta-gami(DE3)pLysS
(Novagen) cells carrying pMK3271 and pMK3272, respectively) were precultured
overnight in 700ml LB medium (350ml per 500ml Sakaguchi flask) supplemented
with 100mgml 1 ampicillin and 34mgml 1 chloramphenicol. The cells collected
from the cultures (B75 or 700ml culture) were inoculated in 1.5 or 13.5 l LB
medium (1.5 per 2 l Sakaguchi flask) supplemented with the same antibiotics, and
aerobically cultured at 37 1C, until A600 reached 0.50–1.0. Isopropyl-b-D-thioga-
lactopyranoside was then added to obtain a final concentration of 25 mM and cell
cultivation was continued further at 16 1C under aerobic conditions for 5 days.
The conditions for expression were determined as described in Supplementary
Methods and Supplementary Table S1. The crude extract was prepared as
described29. The D62C5orf33 protein was purified as described in Supplementary
Methods and the purified protein was regarded as purified C5orf33 protein.
Transfection and indirect immunofluorescence microscopy. HEK293A cells
cultivated in Dulbecco’s modification of Eagle’s minimal essential medium
containing 10% fetal bovine serum (DMEMS) supplemented with penicillin
(50 mgml 1) and streptomycin (50 mgml 1) on coverslips at 37 1C were trans-
fected with pMK3602 or pMK3603 by Lipofectamine 2000 (Invitrogen), and fur-
ther cultivated for 2 days at 37 1C. The transfected HEK293A cells were stained
with MitoTracker Red CMXRos (500 nM in fresh DMEMS; Molecular Probes) for
45min, washed with PBS, fixed with 3.7% formaldehyde in PBS, permeabilized
with 0.2% Triton X-100 in PBS and blocked using PBS containing 3% bovine serum
albumin (BSA). The primary antibody was rabbit anti-FLAG (Sigma) and the
secondary antibody was AlexaFluor 488-conjugated anti-rabbit IgG (Invitrogen).
Images were acquired using an inverted FV1000-D IX81 (Olympus, Tokyo, Japan)
microscope.
Absolute qPCR. Human total RNAs were purchased from Clontech and Agilent
Technologies. The synthesized mRNAs of GAPDH, human NADK, and C5orf33
variant 1 (Supplementary Fig. S1) were prepared using the in vitro Transcription
T7 kit (Takara, Otsu, Japan) using as templates, respectively, pMK3420, pMK3421,
and pMK3422 linearized by XhoI. The molar concentration of the synthesized
mRNAs was calculated from A260, and the calculated molecular mass of the
synthesized mRNAs (GAPDH, 413 kDa; human NADK, 943 kDa; C5orf33 variant
1, 1,193 kDa). RNA was isolated from siRNA-transfected HEK293A cells using
Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan). cDNAs were prepared
from RNA and quantitated by absolute qPCR using LineGene (BioFlux, Tokyo,
Japan) and SYBR Green Real-time PCR Master Mix (Toyobo) as described in
Supplementary Methods.
siRNA transfection. The siRNA duplexes (Sigma) for knockdown of C5orf33 gene
are listed in Supplementary Table S2. MISSION siRNA Universal Negative Control
#1 (control siRNA; Sigma) was used as siRNA duplex for a negative control. Other
details were described in Supplementary Methods. Cell viability of the transfected
HEK293A cells was measured using 3-(4,5-di-methylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) or calcein AM (Molecular Probes) and intracellular ROS
of the cells were detected as described23,33,46 and in Supplementary Methods.
Western blotting. Proteins were separated by SDS–PAGE47 and analysed using
anti-C5orf33 (Abnova, rabbit polyclonal, 1:2,500 dilution or 1:312,500 as in
Supplementary Fig. S4), anti-cytochrome C oxidase subunit II (EPR3314)
(CoxII; Abcam, rabbit monoclonal, 1:10,000), anti-GAPDH (6C5) (loading control;
Abcam, mouse monoclonal, 1:500), anti-human NADK (Abnova, mouse
monoclonal, 1:500 as in Supplementary Fig. S4) antibodies, which were diluted in
Can Get Signal solution 1 (Toyobo). Horseradish peroxide–conjugated anti-rabbit
IgG (HRP–anti-rabbit IgG; Amersham Biosciences) and HRP–anti-mouse IgG
(Amersham Biosciences) were diluted in Can Get Signal solution 2 (Toyobo) at
dilutions of 1:2,000 and 1:10,000, respectively. MagicMark XP Western Standard
(Invitrogen) or Precision Plus Protein Standard (Bio-Rad) was used as the
standard. For proteins in lysates of transfected HEK293A cells, cells in 4 0.6ml
transfection-mixture were collected by treatment with trypsin/EDTA solution
(Nacalai Tesque), suspended and boiled for 10min in 48 ml 1 SDS buffer.
Signal intensities were estimated using ImageQuant TL.
Preparation of mitochondria. From transfected HEK293A cells, we prepared
mitochondria using the Mitochondria Isolation Kit for Cultured Cells
(MitoSciences). Details are described in Supplementary Methods.
Other analytical methods. Protein concentration of the crude extract was
determined by the Bradford method48, and BSA was used for a standard. The
concentration of purified C5orf33 protein was determined using A280. A solution
containing purified C5orf33 protein with A280 of 1.0 was calculated to contain
0.9mgml 1 from the molar extinction coefficient (51,255), and the calculated
molecular mass (46,353Da) of the C5orf33 protein using ExPASy (http://
br.expasy.org/tools/protparam.html). The molecular mass of the enzyme was
estimated by gel filtration chromatography as described previously29. The
phylogenetic tree was constructed as described in Supplementary Methods.
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